FDA Clears United Therapeutics to Proceed With SUMMIT Trial
United Therapeutics said the FDA cleared its investigational new drug application to proceed with the phase 2 SUMMIT trial of treprostinil SMI in PH-COPD.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.